These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16020035)

  • 1. Total lung deposition of ultrafine particles in elderly subjects during controlled breathing.
    Kim CS; Jaques PA
    Inhal Toxicol; 2005; 17(7-8):387-99. PubMed ID: 16020035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of total lung deposition of inhaled ultrafine particles in healthy men and women.
    Jaques PA; Kim CS
    Inhal Toxicol; 2000 Aug; 12(8):715-31. PubMed ID: 10880153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total respiratory tract deposition of fine micrometer-sized particles in healthy adults: empirical equations for sex and breathing pattern.
    Kim CS; Hu SC
    J Appl Physiol (1985); 2006 Aug; 101(2):401-12. PubMed ID: 16849812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrafine particle deposition in subjects with asthma.
    Chalupa DC; Morrow PE; Oberdörster G; Utell MJ; Frampton MW
    Environ Health Perspect; 2004 Jun; 112(8):879-82. PubMed ID: 15175176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deposition efficiency of inhaled particles (15-5000 nm) related to breathing pattern and lung function: an experimental study in healthy children and adults.
    Rissler J; Gudmundsson A; Nicklasson H; Swietlicki E; Wollmer P; Löndahl J
    Part Fibre Toxicol; 2017 Apr; 14(1):10. PubMed ID: 28388961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrafine particle deposition in humans during rest and exercise.
    Daigle CC; Chalupa DC; Gibb FR; Morrow PE; Oberdörster G; Utell MJ; Frampton MW
    Inhal Toxicol; 2003 May; 15(6):539-52. PubMed ID: 12692730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary effects of inhaled ultrafine particles.
    Oberdörster G
    Int Arch Occup Environ Health; 2001 Jan; 74(1):1-8. PubMed ID: 11196075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of particle parameters in the evaluation of exposure-dose-response relationships of inhaled particles.
    Oberdorster G
    Inhal Toxicol; 1996; 8 Suppl():73-89. PubMed ID: 11542496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxides and macrophages in the toxicity of fine particulate matter in rats.
    Laskin DL; Morio L; Hooper K; Li TH; Buckley B; Turpin B
    Res Rep Health Eff Inst; 2003 Dec; (117):1-51; discussion 53-63. PubMed ID: 15035594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of exposure to ultrafine carbon particles in healthy subjects and subjects with asthma.
    Frampton MW; Utell MJ; Zareba W; Oberdörster G; Cox C; Huang LS; Morrow PE; Lee FE; Chalupa D; Frasier LM; Speers DM; Stewart J
    Res Rep Health Eff Inst; 2004 Dec; (126):1-47; discussion 49-63. PubMed ID: 15768531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung deposition of fine and ultrafine particles outdoors and indoors during a cooking event and a no activity period.
    Mitsakou C; Housiadas C; Eleftheriadis K; Vratolis S; Helmis C; Asimakopoulos D
    Indoor Air; 2007 Apr; 17(2):143-52. PubMed ID: 17391237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrafine particle-lung interactions: does size matter?
    Kreyling WG; Semmler-Behnke M; Möller W
    J Aerosol Med; 2006; 19(1):74-83. PubMed ID: 16551218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Size-resolved respiratory-tract deposition of fine and ultrafine hydrophobic and hygroscopic aerosol particles during rest and exercise.
    Löndahl J; Massling A; Pagels J; Swietlicki E; Vaclavik E; Loft S
    Inhal Toxicol; 2007 Feb; 19(2):109-16. PubMed ID: 17169858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of particulate air pollution and acute mortality: involvement of ultrafine particles?
    Oberdorster G; Gelein RM; Ferin J; Weiss B
    Inhal Toxicol; 1995; 7(1):111-24. PubMed ID: 11541043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability of fine particle deposition in healthy adults: effect of age and gender.
    Bennett WD; Zeman KL; Kim C
    Am J Respir Crit Care Med; 1996 May; 153(5):1641-7. PubMed ID: 8630615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of multiple-path particle dosimetry model for quantifying age specified deposition of particulate matter in human airway.
    Manojkumar N; Srimuruganandam B; Shiva Nagendra SM
    Ecotoxicol Environ Saf; 2019 Jan; 168():241-248. PubMed ID: 30388542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translocation of inhaled ultrafine particles to the brain.
    Oberdörster G; Sharp Z; Atudorei V; Elder A; Gelein R; Kreyling W; Cox C
    Inhal Toxicol; 2004 Jun; 16(6-7):437-45. PubMed ID: 15204759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled exposure of humans with metabolic syndrome to concentrated ultrafine ambient particulate matter causes cardiovascular effects.
    Devlin RB; Smith CB; Schmitt MT; Rappold AG; Hinderliter A; Graff D; Carraway MS
    Toxicol Sci; 2014 Jul; 140(1):61-72. PubMed ID: 24718702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of particle lung doses from the fine and coarse fractions of urban PM-10 aerosols.
    Venkataraman C; Kao AS
    Inhal Toxicol; 1999 Feb; 11(2):151-69. PubMed ID: 10380164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric comparisons of particle deposition and retention in rats and humans.
    Brown JS; Wilson WE; Grant LD
    Inhal Toxicol; 2005; 17(7-8):355-85. PubMed ID: 16020034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.